Press Releases Archives - Page 75 of 103 - Lupin

BSE 2302.10 NSE 2302.70

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2302.10 NSE 2302.70

Lupin Launches Generic Glumetza® HCI ER Tablets in the US

February 2, 2016

Lupin Receives FDA Approval for Generic Generess® Tablets

January 8, 2016

Lupin Launches Generic Ortho Tri-Cyclen® Lo Tablets

January 6, 2016

Lupin Receives FDA Approval for Generic Generess® Tablets

December 28, 2015

Lupin Receives FDA Approval for Potassium Chloride Extended Release Capsules

December 23, 2015

Lupin Receives FDA Approvals for Generic Loestrin® Fe 1/20 and Loestrin®1.5/30 Tablets

November 24, 2015

Lupin Appoints Thierry Volle as President – Europe, Middle-East & Africa (EMEA)

November 5, 2015

Lupin Receives FDA Approval for Generic Loestrin®24 Fe Tablets

November 3, 2015

Lupin receives FDA Approval for Generic Aricept® Tablets

November 3, 2015

Lupin Limited – Quarter II Results, FY2016

October 27, 2015

1 2 … 74 75 76 … 102 103

Search

Hit enter to search or ESC to close